EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSLCAG00010025763
Gene Symbol: ATP1B2B
4 Cross references
203 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSLCAG00010013702
Gene Symbol: ATR
1 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSLCAG00010006919
Gene Symbol: AXL
4 Cross references
187 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSLCAG00010012711
Gene Symbol: LOC108897545
4 Cross references
218 Possible Orthologues:

B2 Bradykinin Receptor

Ensembl ID : ENSLCAG00010018398
Gene Symbol: LOC108875062
2 Cross references
244 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSLCAG00010010850
Gene Symbol: BCL2
4 Cross references
176 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSLCAG00010016185
Gene Symbol: BCL2
2 Cross references
168 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSLCAG00010019389
Gene Symbol: BCL2L1
4 Cross references
216 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSLCAG00010000879
Gene Symbol: BCL2L1
4 Cross references
226 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSLCAG00010023256
Gene Symbol: BCL2L10
4 Cross references
128 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSLCAG00010005409
Gene Symbol: BCR
4 Cross references
205 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSLCAG00010027879
Gene Symbol: SI:DKEY-91M11.5
4 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).